Literature DB >> 20077038

Expression of cyclin D2, P53, Rb and ATM cell cycle genes in brain tumors.

Majid Kheirollahi1, Masoud Mehr-Azin, Naser Kamalian, Parvin Mehdipour.   

Abstract

Cyclin D2, P53, Rb and ATM as cell cycle genes regulate cell growth and proliferation. Considering their roles, we assumed that they have different level of mRNA expression in different grades of brain tumors. To determine this point, we investigated the mRNA expression in two types of brain tumors, including astrocytoma and meningioma. The mRNA of 52 brain tumor samples were extracted; cyclin D2, P53, Rb and ATM mRNA expression was quantified using the real-time quantitative reverse-transcription polymerase chain reaction. We compared mRNA expression of these genes between astrocytoma and meningioma tumors and also between different grades of them. Cyclin D2, P53, Rb and ATM had higher expression in astrocytoma than meningioma tumors. Higher grade (III and IV) of astrocytoma tumors had up-regulation for cyclin D2 and ATM genes, but higher grades of these tumors showed down-regulation of P53 and Rb genes. Analysis of relative expression between two grades of meningioma tumors showed a high down-regulation in grade II related to grade I. Also, cyclin D2, P53, Rb and ATM mRNA expression in each group of tumors (meningioma and astrocytoma) showed a highly positive correlation in lower grades. Considering this fact and also different templates of up- and down-regulation for these genes' interaction in different types of brain tumors, it seems that these genes do not have a unique model of interaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20077038     DOI: 10.1007/s12032-009-9412-8

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  56 in total

Review 1.  Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.

Authors:  S V Ekholm; S I Reed
Journal:  Curr Opin Cell Biol       Date:  2000-12       Impact factor: 8.382

Review 2.  Connections between growth and the cell cycle.

Authors:  T P Neufeld; B A Edgar
Journal:  Curr Opin Cell Biol       Date:  1998-12       Impact factor: 8.382

3.  Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma.

Authors:  M B Diccianni; M Omura-Minamisawa; A Batova; T Le; L Bridgeman; A L Yu
Journal:  Int J Cancer       Date:  1999-01-05       Impact factor: 7.396

Review 4.  ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.

Authors:  Erik Meulmeester; Yaron Pereg; Yosef Shiloh; Aart G Jochemsen
Journal:  Cell Cycle       Date:  2005-09-29       Impact factor: 4.534

Review 5.  Role of the Rb/E2F pathway in cell growth control.

Authors:  J R Nevins; G Leone; J DeGregori; L Jakoi
Journal:  J Cell Physiol       Date:  1997-11       Impact factor: 6.384

Review 6.  Genetic instability in human tumors.

Authors:  Stavroula Raptis; Bharati Bapat
Journal:  EXS       Date:  2006

Review 7.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

8.  Functional consequences of ATM sequence variants for chromosomal radiosensitivity.

Authors:  Sara Gutiérrez-Enríquez; Marie Fernet; Thilo Dörk; Michael Bremer; Anthony Lauge; Dominique Stoppa-Lyonnet; Norman Moullan; Sandra Angèle; Janet Hall
Journal:  Genes Chromosomes Cancer       Date:  2004-06       Impact factor: 5.006

9.  Lack of defective expression of the ATM gene in sporadic breast cancer tissues and cell lines.

Authors:  S Kovalev; A Mateen; A I Zaika; B J O'Hea; U M Moll
Journal:  Int J Oncol       Date:  2000-04       Impact factor: 5.650

10.  Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.

Authors:  J Lukas; J Bartkova; M Welcker; O W Petersen; G Peters; M Strauss; J Bartek
Journal:  Oncogene       Date:  1995-06-01       Impact factor: 9.867

View more
  13 in total

1.  Linking ATM Promoter Methylation to Cell Cycle Protein Expression in Brain Tumor Patients: Cellular Molecular Triangle Correlation in ATM Territory.

Authors:  P Mehdipour; F Karami; Firouzeh Javan; M Mehrazin
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer.

Authors:  Parvin Mehdipour; Marzieh Mahdavi; Javad Mohammadi-Asl; Morteza Atri
Journal:  Med Oncol       Date:  2010-04-16       Impact factor: 3.064

3.  Promotion of liver and lung tumorigenesis in DEN-treated cytoglobin-deficient mice.

Authors:  Le Thi Thanh Thuy; Takashi Morita; Kayo Yoshida; Kenichi Wakasa; Masashi Iizuka; Tomohiro Ogawa; Mami Mori; Yumiko Sekiya; Shinobu Momen; Hiroyuki Motoyama; Kazuo Ikeda; Katsutoshi Yoshizato; Norifumi Kawada
Journal:  Am J Pathol       Date:  2011-06-02       Impact factor: 4.307

4.  Analysis of CDKN2A gene alterations in recurrent and non-recurrent meningioma.

Authors:  Anne Guyot; Mathilde Duchesne; Sandrine Robert; Anne-Sophie Lia; Paco Derouault; Erwan Scaon; Leslie Lemnos; Henri Salle; Karine Durand; François Labrousse
Journal:  J Neurooncol       Date:  2019-11-15       Impact factor: 4.130

5.  Immunohistochemical and genetic markers to distinguish hemangiopericytoma and meningioma.

Authors:  Penglai Zhao; Tongming Zhu; Qisheng Tang; Hongyi Liu; Jianhong Zhu; Wenbin Zhang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  Molecular defects in Moroccan patients with ataxia-telangiectasia.

Authors:  L Jeddane; F Ailal; C Dubois-d'Enghien; O Abidi; I Benhsaien; A Kili; S Chaouki; Y Kriouile; N El Hafidi; H Fadil; R Abilkassem; N Rada; A A Bousfiha; A Barakat; D Stoppa-Lyonnet; H Bellaoui
Journal:  Neuromolecular Med       Date:  2013-01-16       Impact factor: 3.843

7.  Down-regulation of miR-106b suppresses the growth of human glioma cells.

Authors:  Anling Zhang; Jianwei Hao; Kun Wang; Qiang Huang; Kai Yu; Chunsheng Kang; Guangxiu Wang; Zhifan Jia; Lei Han; Peiyu Pu
Journal:  J Neurooncol       Date:  2013-02-02       Impact factor: 4.130

Review 8.  Brain tumors: Special characters for research and banking.

Authors:  Majid Kheirollahi; Sepideh Dashti; Zahra Khalaj; Fatemeh Nazemroaia; Parvin Mahzouni
Journal:  Adv Biomed Res       Date:  2015-01-06

9.  ATM in breast and brain tumors: a comprehensive review.

Authors:  Mehrdad Asghari Estiar; Parvin Mehdipour
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

10.  Variation of ATM Gene Expression in Peripheral Blood Cells of Sporadic Breast Carcinomas in Iranian Patients.

Authors:  Mohsen Foroughizadeh; Hossein Mozdarani; Keyvan Majidzadeh-A; Ahmad Kaviani
Journal:  Avicenna J Med Biotechnol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.